首页> 外文期刊>Proteomics >A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter
【24h】

A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter

机译:一种全球蛋白质组学方法可鉴定GPVI激活的血小板中的新型磷酸化信号蛋白:涉及G6f(一种新型的Grb2结合膜适配器)

获取原文
获取原文并翻译 | 示例
           

摘要

Collagen-related peptide (CRP) stimulates powerful activation of platelets through the glycoprotein VI (GPVI)-FcR gamma-chain complex. We have combined proteomics and traditional biochemistry approaches to study the proteome of CRP-activated platelets, focusing in detail on tyrosine phosphorylation. In two separate approaches, phosphotyrosine immunoprecipitations followed by 1-D-PAGE, and 2-DE, were used for protein separation. Proteins were identified by MS. By following these approaches, 96 proteins were found to undergo PTM in response to CRP in human platelets, including 11 novel platelet proteins such as Dok-1, SPIN90, osteoclast stimulating factor 1, and beta-Pix. Interestingly, the type I transmembrane protein G6f was found to be specifically phosphorylated on Tyr-281 in response to platelet activation by CRP, providing a docking site for the adapter Grb2. G6f tyrosine phoshporylation was also found to take place in response to collagen, although not in response to the G protein-coupled receptor agonists, thrombin and ADP. Further, we also demonstrate for the first time that Grb2 and its homolog Gads are tyrosine-phosphorylated in CRP-stimulated platelets. This study provides new insights into the mechanism of platelet activation through the GPVI collagen receptor, helping to build the basis for the development of new drug targets for thrombotic disease.
机译:胶原蛋白相关肽(CRP)通过糖蛋白VI(GPVI)-FcRγ链复合物刺激血小板的强大活化。我们结合蛋白质组学和传统的生物化学方法来研究CRP活化的血小板的蛋白质组,重点是酪氨酸磷酸化。在两种单独的方法中,磷酸酪氨酸免疫沉淀后再进行1-D-PAGE和2-DE用于蛋白质分离。通过MS鉴定蛋白质。通过遵循这些方法,发现96种蛋白质响应人类血小板中的CRP而经历PTM,包括11种新型血小板蛋白质,例如Dok-1,SPIN90,破骨细胞刺激因子1和β-Pix。有趣的是,发现I型跨膜蛋白G6f在Tyr-281上特异性磷酸化,以响应CRP激活的血小板,从而为衔接子Grb2提供了对接位点。 G6f酪氨酸磷酸化也被发现是对胶原蛋白的反应,尽管不是对G蛋白偶联受体激动剂凝血酶和ADP的反应。此外,我们还首次证明了在CRP刺激的血小板中Grb2及其同系物Gads被酪氨酸磷酸化。这项研究为通过GPVI胶原蛋白受体活化血小板的机制提供了新见解,有助于为开发针对血栓性疾病的新药物靶标奠定基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号